Filing Details
- Accession Number:
- 0000950170-24-026633
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-05 20:09:57
- Reporting Period:
- 2024-03-02
- Accepted Time:
- 2024-03-05 20:09:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1792044 | Viatris Inc | VTRS | Pharmaceutical Preparations (2834) | 834364296 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1848812 | (Sean) Xiangyang Ni | 1000 Mylan Boulevard Canonsburg PA 15317 | President, Greater China | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-02 | 17,011 | $0.00 | 81,669 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-03-02 | 7,195 | $0.00 | 88,864 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-03-02 | 952 | $0.00 | 89,816 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-03-03 | 13,627 | $0.00 | 103,443 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-03-03 | 671 | $0.00 | 104,114 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-03-04 | 7,564 | $0.00 | 111,678 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-03-04 | 658 | $0.00 | 112,336 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-04 | 17,755 | $12.54 | 94,581 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-04 | 3,777 | $12.36 | 90,804 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Restricted Stock Units | Acquisiton | 2024-03-02 | 17,011 | $0.00 | 17,011 | $0.00 |
| Common Stock | Performance Restricted Stock Units | Disposition | 2024-03-02 | 17,011 | $0.00 | 17,011 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2024-03-02 | 7,195 | $0.00 | 7,195 | $0.00 |
| Common Stock | Dividend Equivalent Units | Disposition | 2024-03-02 | 951 | $0.00 | 951 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2024-03-03 | 13,627 | $0.00 | 13,627 | $0.00 |
| Common Stock | Dividend Equivalent Units | Disposition | 2024-03-03 | 671 | $0.00 | 671 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2024-03-04 | 7,564 | $0.00 | 7,564 | $0.00 |
| Common Stock | Dividend Equivalent Units | Disposition | 2024-03-04 | 658 | $0.00 | 658 | $0.00 |
| Common Stock | Restricted Stock Units | Acquisiton | 2024-03-04 | 37,945 | $0.00 | 37,945 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 17,011 | No | 4 | A | Direct | ||
| 0 | No | 4 | M | Direct | ||
| 0 | No | 4 | M | Direct | ||
| 0 | No | 4 | M | Direct | ||
| 27,254 | No | 4 | M | Direct | ||
| 1,342 | No | 4 | M | Direct | ||
| 7,564 | No | 4 | M | Direct | ||
| 658 | No | 4 | M | Direct | ||
| 37,945 | No | 4 | A | Direct |
Footnotes
- Fractional shares have been rounded up in connection with the settlement described in footnote 11 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
- Fractional shares have been rounded up in connection with the settlement described in footnote 13 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
- Fractional shares have been rounded up in connection with the settlement described in footnote 15 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
- Shares sold to satisfy the tax liability associated with the vesting and settlement of the performance restricted stock units (PRSUs) granted on March 2, 2021, the RSUs granted on March 2, 2021, the RSUs granted on March 4, 2022, the RSUs granted on March 3, 2023 and each such grant's related dividend equivalent units (DEUs).
- Represents the weighted average price of the reporting person's disposition of 17,755 shares of common stock in transactions ranging from $12.375 to $12.59. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote.
- Represents the weighted average price of the reporting person's disposition of 3,777 shares of common stock in transactions ranging from $12.27 to $12.36. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote.
- Amount includes DEUs that accrued with respect to the PRSUs previously granted on March 2, 2021 and vest on the same schedule as the underlying PRSUs. Fractional shares with respect to such DEUs were rounded up pursuant to the terms of the PRSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
- Each PRSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). The PRSUs were initially granted on March 2, 2021, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs vested on March 2, 2024.
- Each RSU represents the right to receive one share of common stock of Viatris. 7,195 of the RSUs granted on March 2, 2021 vested on each of March 2, 2022, March 2, 2023 and March 2, 2024.
- Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11.
- Represents DEUs that accrued with respect to the RSUs previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs.
- Each RSU represents the right to receive one share of common stock of Viatris. 13,627 of the RSUs granted on March 3, 2023 vested on March 3, 2024, and 13,627 will vest on each of March 3, 2025 and March 3, 2026.
- Represents DEUs that accrued with respect to the RSUs previously granted on March 3, 2023 and vest on the same schedule as the underlying RSUs.
- Each RSU represents the right to receive one share of common stock of Viatris. 7,563 of the RSUs granted on March 4, 2022 vested on March 4, 2023, 7,564 vested on March 4, 2024 and 7,564 will vest on March 4, 2025.
- Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2022 and vest on the same schedule as the underlying RSUs.
- Each RSU represents the right to receive one share of common stock of Viatris. 12,649 of the RSUs granted on March 4, 2024 will vest on March 4, 2025, 12,648 will vest on March 4, 2026 and 12,648 will vest on March 4, 2027.
Billionaire Hedge Funds
